- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Focus on Rheumatoid Arthritis
The Rheumatology Network rheumatoid arthritis clinical focus page provides information on the latest rheumatoid arthritis news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for rheumatoid arthritis drugs.
Rheumatology Network: CCR East Recap
May 27, 2022
Look back on Rheumatology Network's Congress of Clinical Rheumatology (CCR) East's conference coverage.
Glucocorticoids Linked to Increase in COVID-19 Hospital Admissions in Patients with RA
May 26, 2022
COVID-19 has raised additional concerns for rheumatologists, especially regarding health care for patients with rheumatic diseases.
Patient-Reported Outcomes: Rheumatoid Arthritis, Psoriatic Arthritis, and Myositis
May 24, 2022
Clinicians give their opinions on patient-reported outcome measures regarding both initial diagnosis and management of patients with rheumatic disease.
Rheumatology Network's Top 5: May 21, 2022
May 21, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending May 21, 2022.
Janet Pope, MD, MPH: Treating Unresponsive Rheumatoid Arthritis
May 18, 2022
Janet Pope, MD, MPH, explains her treatment strategies for unresponsive patients with rheumatoid arthritis as well as clinical pearls of 2021.
Arthur Kavanaugh, MD: Hot Topics in Rheumatoid Arthritis and Psoriatic Arthritis
May 16, 2022
Arthur Kavanaugh, MD, discusses his recent CCR East presentations “The Immunopathogenesis of Psoriatic Arthritis and Immunologically Targeted Therapy” and “Hot Topics in Rheumatoid Arthritis.”
Rheumatology Network's Top 5: April 30, 2022
April 30, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending April 30, 2022.
RAPID3 Questionnaire May Reduce Outpatient Visits in Patients With RA
April 27, 2022
Approximately a quarter of RAPID3 assessments, confirmed with 92% accuracy by DAS28 scores, reported patients had low disease activity and could, therefore, postpone routine clinical visits.
Low Socioeconomic Status Linked to Worse Outcomes in Patients With RA
April 27, 2022
Mental and physical illnesses, such as rheumatoid arthritis, are often driven by social, environmental, and economic factors and may affect disease outcomes.
Strict Treat-to-Target Approach Beneficial for Patients With RA
April 18, 2022
White a treat-to-target strategy is an important part of managing patients with rheumatoid arthritis, a more controlled implementation with closer follow-up appointments and patient education yielded better outcomes.